154 related articles for article (PubMed ID: 8621600)
1. New molecular and structural determinants involved in beta 2-adrenergic receptor desensitization and sequestration. Delineation using chimeric beta 3/beta 2-adrenergic receptors.
Jockers R; Da Silva A; Strosberg AD; Bouvier M; Marullo S
J Biol Chem; 1996 Apr; 271(16):9355-62. PubMed ID: 8621600
[TBL] [Abstract][Full Text] [Related]
2. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor.
Liggett SB; Freedman NJ; Schwinn DA; Lefkowitz RJ
Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3665-9. PubMed ID: 8386380
[TBL] [Abstract][Full Text] [Related]
3. A central role for beta-arrestins and clathrin-coated vesicle-mediated endocytosis in beta2-adrenergic receptor resensitization. Differential regulation of receptor resensitization in two distinct cell types.
Zhang J; Barak LS; Winkler KE; Caron MG; Ferguson SS
J Biol Chem; 1997 Oct; 272(43):27005-14. PubMed ID: 9341139
[TBL] [Abstract][Full Text] [Related]
4. A highly conserved tyrosine residue in G protein-coupled receptors is required for agonist-mediated beta 2-adrenergic receptor sequestration.
Barak LS; Tiberi M; Freedman NJ; Kwatra MM; Lefkowitz RJ; Caron MG
J Biol Chem; 1994 Jan; 269(4):2790-5. PubMed ID: 7507928
[TBL] [Abstract][Full Text] [Related]
5. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
Nantel F; Bonin H; Emorine LJ; Zilberfarb V; Strosberg AD; Bouvier M; Marullo S
Mol Pharmacol; 1993 Apr; 43(4):548-55. PubMed ID: 8386307
[TBL] [Abstract][Full Text] [Related]
6. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
Rousseau G; Nantel F; Bouvier M
Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905
[TBL] [Abstract][Full Text] [Related]
7. The olfactory G protein G(alphaolf) possesses a lower GDP-affinity and deactivates more rapidly than G(salphashort): consequences for receptor-coupling and adenylyl cyclase activation.
Liu HY; Wenzel-Seifert K; Seifert R
J Neurochem; 2001 Jul; 78(2):325-38. PubMed ID: 11461968
[TBL] [Abstract][Full Text] [Related]
8. Involvement of tyrosine residues located in the carboxyl tail of the human beta 2-adrenergic receptor in agonist-induced down-regulation of the receptor.
Valiquette M; Bonin H; Hnatowich M; Caron MG; Lefkowitz RJ; Bouvier M
Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5089-93. PubMed ID: 2164220
[TBL] [Abstract][Full Text] [Related]
9. c-Src tyrosine kinase binds the beta 2-adrenergic receptor via phospho-Tyr-350, phosphorylates G-protein-linked receptor kinase 2, and mediates agonist-induced receptor desensitization.
Fan G; Shumay E; Malbon CC; Wang H
J Biol Chem; 2001 Apr; 276(16):13240-7. PubMed ID: 11278940
[TBL] [Abstract][Full Text] [Related]
10. A proline-rich region of the third intracellular loop imparts phenotypic beta 1-versus beta 2-adrenergic receptor coupling and sequestration.
Green SA; Liggett SB
J Biol Chem; 1994 Oct; 269(42):26215-9. PubMed ID: 7929336
[TBL] [Abstract][Full Text] [Related]
11. Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the beta2-adrenergic receptor.
Tepe NM; Liggett SB
J Recept Signal Transduct Res; 2000 Jan; 20(1):75-85. PubMed ID: 10711498
[TBL] [Abstract][Full Text] [Related]
12. Beta2-adrenergic receptor lysosomal trafficking is regulated by ubiquitination of lysyl residues in two distinct receptor domains.
Xiao K; Shenoy SK
J Biol Chem; 2011 Apr; 286(14):12785-95. PubMed ID: 21330366
[TBL] [Abstract][Full Text] [Related]
13. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of acute desensitization of the beta2AR-adenylyl cyclase pathway in human airway smooth muscle.
Penn RB; Panettieri RA; Benovic JL
Am J Respir Cell Mol Biol; 1998 Aug; 19(2):338-48. PubMed ID: 9698608
[TBL] [Abstract][Full Text] [Related]
15. Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors.
Guimond J; Mamarbachi AM; Allen BG; Rindt H; Hébert TE
Cell Signal; 2005 Jan; 17(1):49-58. PubMed ID: 15451024
[TBL] [Abstract][Full Text] [Related]
16. Identification of a region required for subtype-specific agonist-induced sequestration of the m2 muscarinic acetylcholine receptor.
Goldman PS; Schlador ML; Shapiro RA; Nathanson NM
J Biol Chem; 1996 Feb; 271(8):4215-22. PubMed ID: 8626765
[TBL] [Abstract][Full Text] [Related]
17. Subtype-selective desensitization of alpha 2-adrenergic receptors. Different mechanisms control short and long term agonist-promoted desensitization of alpha 2C10, alpha 2C4, and alpha 2C2.
Eason MG; Liggett SB
J Biol Chem; 1992 Dec; 267(35):25473-9. PubMed ID: 1334095
[TBL] [Abstract][Full Text] [Related]
18. Chimeric mutagenesis of putative G-protein coupling domains of the alpha2A-adrenergic receptor. Localization of two redundant and fully competent gi coupling domains.
Eason MG; Liggett SB
J Biol Chem; 1996 May; 271(22):12826-32. PubMed ID: 8662784
[TBL] [Abstract][Full Text] [Related]
19. Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization.
Yu SS; Lefkowitz RJ; Hausdorff WP
J Biol Chem; 1993 Jan; 268(1):337-41. PubMed ID: 8380158
[TBL] [Abstract][Full Text] [Related]
20. The beta2-adrenergic receptor/betaarrestin complex recruits the clathrin adaptor AP-2 during endocytosis.
Laporte SA; Oakley RH; Zhang J; Holt JA; Ferguson SS; Caron MG; Barak LS
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3712-7. PubMed ID: 10097102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
